Add BrightSurf on Google Email

Science News Archive January 2002


Page 1 of 7

Cells on the verge of suicide

A team of researchers has identified the entire series of proteins that relay a message of survival from a neuron to a glial cell in the fruit fly Drosophila melanogaster, shedding light on how cells 'know' whether to survive or perish. This discovery may lead to novel treatments for diseases such as Alzheimer's and cancer.

SourceRockefeller University·JournalDevelopmental Cell·DateJan 31, 2002

Tidying up transcription factors

Researchers James E. Darnell and Ali H. Brivanlou propose a reclassification of all known transcription factors, grouping them by their behavior rather than physical structure. This framework aims to provide a better understanding of how cells 'read' genetic instructions and may lead to new drug therapies for diseases such as cancer an...

SourceRockefeller University·JournalScience·DateJan 31, 2002

E. coli bacteria make Alzheimer’s-linked fibers

Certain strains of E. coli produce amyloid fibers similar to those found in Alzheimer's disease, forming a meshwork around the bacteria in biofilms. This discovery raises questions about the role of bacterial infections in amyloid diseases, including Alzheimer's, and may lead to new treatment options.

SourceWashU Medicine·JournalScience·DateJan 31, 2002

Pheromones control sex discrimination in mice

Researchers have found that pheromones play a crucial role in mice's gender recognition. The knockout mice, which lacked a gene for a pheromone receptor, were unable to recognize males and displayed unusual mating behavior. This breakthrough provides new insights into the neural circuitry responsible for sex discrimination in mice.

Mammography screening-the debate continues

A recent meta-analysis and follow-up study found no immediate life-saving effect of mammography screening, but suggested that it may reduce breast cancer mortality after several years. Researchers argue that the analysis must focus on case-fatality rates rather than overall mortality rates to accurately evaluate the benefits.

SourceThe Lancet_DELETED·JournalThe Lancet·DateJan 31, 2002

A novel cardiac glycogen storage disease

A novel cardiac glycogen storage disease has been identified through research published in the Journal of Clinical Investigation. The study sheds new light on the genetic causes and consequences of this rare condition, offering potential avenues for improved diagnosis and therapy.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateJan 30, 2002

Research uncovers new treatment target for cystic fibrosis patients’ lung infection

Researchers found Pseudomonas aeruginosa thrives in low-oxygen environments of the airways, adapting to remove oxygen and producing protective sugar coatings. This discovery suggests a new strategy to target specific enzymes critical for bacterial survival, offering hope for improved treatment options.

SourceUniversity of North Carolina at Chapel Hill·JournalJournal of Clinical Investigation·DateJan 30, 2002

Fas signaling and cardiac hypertrophy

Research on Fas signaling reveals its involvement in the development of cardiac hypertrophy, a condition characterized by abnormal heart growth. Understanding this mechanism is crucial for developing effective treatments to manage cardiac hypertrophy and associated diseases.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateJan 30, 2002

New test detects colon cancer gene

A new test has detected colon cancer gene mutations in about 60% of early-stage colorectal cancer patients, with no false positive tests in healthy individuals. The test's high accuracy and low risk of false positives make it a promising tool for early detection and prevention.

SourceHoward Hughes Medical Institute·JournalNew England Journal of Medicine·DateJan 30, 2002

New technique speeds gene research in mammalian cells

Researchers at Cold Spring Harbor Laboratory have developed a new technique for carrying out genetic analysis directly in mammalian cells, enabling them to switch off or switch on genes in mouse cells. This ability allows researchers to infer gene function, identify potential cancer therapies, and discover new properties in cells.

SourceCold Spring Harbor Laboratory·JournalProceedings of the National Academy of Sciences·DateJan 29, 2002

Magnetic stimulation may be as effective as electroconvulsive therapy in treating severe depression

A University of Illinois study suggests that repetitive transcranial magnetic stimulation (rTMS) is a promising alternative to electroconvulsive therapy (ECT) for treating severe depression, with better tolerability and fewer side effects. rTMS showed significant improvement in depression scores, with a 55% reduction in the treatment g...

SourceUniversity of Illinois Chicago·JournalBiological Psychiatry·DateJan 29, 2002

Dead leave stain of distress on mortuary workers

A study found that military personnel assigned to mortuary duty during the Gulf War experienced increased physical symptoms, with those handling bodies showing the most dramatic increases. The researchers suggest that this may be due to an increased awareness of one's own body or concern about dismissed physical symptoms.

SourceCenter for Advancing Health·JournalPsychosomatic Medicine·DateJan 29, 2002

Men with higher levels of PCBs more likely to father boys

A recent study published in the Journal of Occupational and Environmental Medicine found that men with higher levels of polychlorinated biphenyls (PCBs) were more likely to father boys. Researchers analyzed data from 208 children born to 101 families, where PCB levels were detectable in both fathers and mothers.

SourceMichigan State University·JournalJournal of Occupational and Environmental Medicine·DateJan 28, 2002

Genetica, Inc. develops high throughput RNAi tool for drug target validation

Researchers at Genetica and Cold Spring Harbor Laboratory have developed a cost-effective method for determining the role of specific genes using RNAi. This approach enables stable silencing of gene expression in mammalian cells, allowing for rapid assessment of gene function, previously limited to plants and certain model organisms.

SourceFeinstein Kean Healthcare·JournalProceedings of the National Academy of Sciences·DateJan 28, 2002